DB05948InvestigationalSmall molecule
MD-0727 is a novel, potent cholesterol absorption inhibitor (CAI) under investigation for the treatment of hypercholesterolemia (high cholesterol.
- Mechanism
- Curator reviewed
MD-0727 works in a unique manner compared with traditional cholesterol medications known as statins. It reduces the amount of cholesterol absorbed from the digestive tract, whereas statins inhibit the production of cholesterol in the liver.
- Primary indication
- Investigated for use/treatment in hyperlipidemia.Curator reviewed
- Code names
- MD-0727
What you can answer from here — as of April 02, 2025
Which companies are running trials of MD-0727, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account